GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » Price-to-Owner-Earnings

Alfresa Holdings (Alfresa Holdings) Price-to-Owner-Earnings : (As of Jun. 02, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings Price-to-Owner-Earnings?

As of today (2024-06-02), Alfresa Holdings's share price is $13.42. Alfresa Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Alfresa Holdings's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Alfresa Holdings was 41.48. The lowest was 11.88. And the median was 20.70.


ALFRY's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 13.965
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-02), Alfresa Holdings's share price is $13.42. Alfresa Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.05. Therefore, Alfresa Holdings's PE Ratio for today is 12.73.

As of today (2024-06-02), Alfresa Holdings's share price is $13.42. Alfresa Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was $0.96. Therefore, Alfresa Holdings's PE Ratio without NRI for today is 13.95.

During the past 13 years, Alfresa Holdings's highest PE Ratio without NRI was 22.42. The lowest was 10.55. And the median was 15.51.


Alfresa Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Alfresa Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Price-to-Owner-Earnings Chart

Alfresa Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alfresa Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alfresa Holdings's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Alfresa Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alfresa Holdings's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's Price-to-Owner-Earnings falls into.



Alfresa Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Alfresa Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=13.42/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alfresa Holdings  (GREY:ALFRY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Alfresa Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (Alfresa Holdings) Business Description

Traded in Other Exchanges
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines